Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 876-900 of 946 matching filings.

Per page
25
Current page
36
4

FORM 4 SUBMISSION

Filing date
14 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
14 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
13 May 2014
Reporting date
13 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2014
Reporting date
08 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36297

10-K

Filing date
28 Mar 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
26 Mar 2014
Reporting date
26 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
21 Mar 2014
Reporting date
17 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2014
Reporting date
04 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Mar 2014
Reporting date
04 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
05 Mar 2014
Reporting date
04 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
04 Mar 2014
Reporting date
26 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
24 Feb 2014
Reporting date
18 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88023

SCHEDULE 13G

Filing date
24 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-193963

S-8

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
11 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .